| Application no. and date | 10824148.0 (espacenet) (Federated) (European Patent Register), 20101015 | | Patent/reg. no. and date | DK/EP 2488033, 20190612 | | Publication date | 20120822 | | Priority no. and date | US 252213 P, 20091016 | | EP pub. no. and date |
EP 2488033 20120822 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/159079 | | Inventor | DUMBLE, Melissa, c/o GlaxoSmithKline
Global Patents Dept.
1250 South Collegeville Road
P. O. Box 5089
Collegeville, Pennsylvania 19426, US,
KUMAR, Rakesh, c/o GlaxoSmithKline
Global Patents Dept.
1250 South Collegeville Road
P.O. Box 5089
Collegeville, Pennsylvania 19426, US,
LAQUERRE, Sylvie, c/o GlaxoSmithKline
Global Patents Dept.
1250 South Collegeville Road
P. O. Box 5089
Collegeville, Pennsylvania 19426, US,
LEBOWITZ, Peter, c/o GlaxoSmithKline
Global Patents Dept.
1250 South Collegeville Road
P. O. Box 5089
Collegeville, Pennsylvania 19426, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 31/519 (2006.01) , A61P 35/00 (2006.01) | | Title | Kombination, der omfatter en MEK-hæmmer og en B-raf-hæmmer | | Int. application no. | US2010052808 | | Int. publication no. | WO2011047238 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
